A phase I trial of the CDK 4/6 inhibitor palbociclib in pediatric patients with progressive brain tumors: A Pediatric Brain Tumor Consortium study (PBTC-042).
Van Mater D, Gururangan S, Becher O, Campagne O, Leary S, Phillips JJ, Huang J, Lin T, Poussaint TY, Goldman S, Baxter P, Dhall G, Robinson G, DeWire-Schottmiller M, Hwang EI, Stewart CF, Onar-Thomas A, Dunkel IJ, Fouladi M.
Van Mater D, et al. Among authors: dhall g.
Pediatr Blood Cancer. 2021 Apr;68(4):e28879. doi: 10.1002/pbc.28879. Epub 2021 Jan 6.
Pediatr Blood Cancer. 2021.
PMID: 33405376
Free PMC article.
Clinical Trial.